These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15767942)

  • 1. [Postnatal steroid treatment in preterm infants: risk/benefit ratio].
    Baud O
    J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Suppl):S118-26. PubMed ID: 15767942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Postnatal Steroids.
    Halliday HL
    Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001144. PubMed ID: 12535400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001144. PubMed ID: 10796416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postnatal dexamethasone therapy for the prevention of chronic lung disease.
    Vermont Oxford Network Steroid Study Group
    Pediatrics; 2001 Sep; 108(3):741-8. PubMed ID: 11533345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Neonatology; 2010; 98(3):217-24. PubMed ID: 20389126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal steroid treatment and brain development.
    Baud O
    Arch Dis Child Fetal Neonatal Ed; 2004 Mar; 89(2):F96-100. PubMed ID: 14977889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study.
    Wong D; Abdel-Latif M; Kent A;
    Arch Dis Child Fetal Neonatal Ed; 2014 Jan; 99(1):F12-20. PubMed ID: 24142624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study.
    Melan N; Pradat P; Godbert I; Pastor-Diez B; Basson E; Picaud JC
    Eur J Pediatr; 2024 Feb; 183(2):677-687. PubMed ID: 37955745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.
    Murphy BP; Inder TE; Huppi PS; Warfield S; Zientara GP; Kikinis R; Jolesz FA; Volpe JJ
    Pediatrics; 2001 Feb; 107(2):217-21. PubMed ID: 11158449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL; Patterson CC; Halahakoon CW;
    Pediatrics; 2001 Feb; 107(2):232-40. PubMed ID: 11158452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
    Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
    Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.
    Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
    Pediatrics; 2002 Jun; 109(6):e85. PubMed ID: 12042579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.